FC Stock News
Thursday, October 26, 2006
Renovis Reports Failed Drug Test
Renovis Inc.'s shares plummeted $10.33 or over 70% to $3.87 after the company reported a failed stroke drug trial.
posted by FC Market News at
10:56 AM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Oracle Competes Against Red Hat
Universal American Receives Buyout Offer
FDA Rejects Antibiotic
First Outsider Named As Wrigley CEO
Oracle To Buy MetaSolv
Stiefel To Acquire Connetics
Indus To Go Private
Hasbro's Earnings Rise
SanDisk Downgraded
Stamps.com's Forecast Disappoints
0 Comments:
Post a Comment
<< Home